31.01.2023 - Development expected to capitalize upon tumor targeting Quatramers MUC1-C could be effective against a number of drug resistant cancers such as metastatic triple negative breast cancer (TNBC), small cell lung cancer (SCLC), merkel cell carcinoma ... Seite 1